ruthenium has been researched along with Cancer of Head in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, B; Hong, XJ; Li, WG; Ling, YY; Mao, ZW; Su, Q; Tan, CP; Wang, WJ; Wu, T; Zhang, CY; Zhou, JY | 1 |
| Amstalden van Hove, ER; Beljaars, L; Bischoff, R; Casini, A; Groothuis, GMM; Halmos, GB; Han, J; Horvatovich, P; Permentier, H; Song, S; Sun, J; Verhoeven, CJ | 1 |
2 other study(ies) available for ruthenium and Cancer of Head
| Article | Year |
|---|---|
Ru(II)-modified TiO
Topics: Animals; Carcinoma, Squamous Cell; Cell Line, Tumor; Cytokines; Head and Neck Neoplasms; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Immunotherapy; Metal Nanoparticles; Mouth Neoplasms; Nanoparticles; Photosensitizing Agents; Rats; RNA, Small Interfering; Ruthenium; Squamous Cell Carcinoma of Head and Neck; Titanium; Tumor Microenvironment | 2022 |
Targeted imaging of integrins in cancer tissues using photocleavable Ru(ii) polypyridine complexes as mass-tags.
Topics: Head and Neck Neoplasms; Humans; Integrin alphaVbeta3; Mass Spectrometry; Peptides, Cyclic; Pyridines; Ruthenium | 2020 |